A wnaiff Ysgrifennydd y Cabinet ddatganiad am argaeledd Savitex ar gyfer dioddefwyr sglerosis ymledol yng Nghymru?
Wedi'i ateb gan Prif Weinidog | Wedi'i ateb ar 18/01/2018
Sativex is routinely available as an option to treat multiple sclerosis sufferers in Wales who meet the clinical criteria specified by the All-Wales Medicines Strategy Group and who are likely to benefit from it. This is for individual clinicians to determine.